Your browser doesn't support javascript.
loading
Photo-Oxygenation: An Innovative New Therapeutic Approach Against Amyloidoses.
Ikeda, Tetsuo; Hori, Yukiko; Sohma, Youhei; Kanai, Motomu; Tomita, Taisuke.
Afiliación
  • Ikeda T; Laboratory of Neuropathology and Neuroscience, Faculty of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Hori Y; Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Sohma Y; Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. yukiko-hori@mol.f.u-tokyo.ac.jp.
  • Kanai M; Laboratory of Synthetic Organic Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Tomita T; Department of Medicinal Chemistry, School of Pharmaceutical Sciences,Wakayama Medical University, Wakayama, Japan.
Adv Exp Med Biol ; 1339: 415-422, 2021.
Article en En | MEDLINE | ID: mdl-35023134
ABSTRACT
Many types of amyloidoses are pathologically characterized by the deposition of amyloid, which is comprised of fibrils formed by abnormally aggregated proteins, in various peripheral tissues and the central nervous system (CNS). Neurodegenerative disorders, such as Alzheimer disease (AD), Parkinson disease (PD), frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), are well-known CNS amyloidoses that are characterized by amyloid deposition both inside and outside of cells. The amyloidogenic proteins of each disease have distinct primary sequences, and they normally function as soluble proteins. However, these proteins all aggregate and form amyloid with a common intermolecular tertiary structure, namely, a cross-ß-sheet structure, finally leading to the onset of each disease. Therefore, inhibition of the aggregation of amyloid proteins or efficient clearance of the already formed amyloids are thought to be promising therapeutic strategies against amyloidoses.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Parkinson / Demencia Frontotemporal / Enfermedad de Alzheimer / Amiloidosis Límite: Humans Idioma: En Revista: Adv Exp Med Biol Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Parkinson / Demencia Frontotemporal / Enfermedad de Alzheimer / Amiloidosis Límite: Humans Idioma: En Revista: Adv Exp Med Biol Año: 2021 Tipo del documento: Article País de afiliación: Japón